FAILDEX失樂園
中文

Prospective Research

The business, the turning points, and the decisions behind them.

FundingUS$2.4M
Some sections are still being researched2 / 4

Sections to complete:02 · 05

01 / WHAT IT BUILT

What the company does

Prospective Research, Inc. is a US biotech founded with a vision to develop novel, lifesaving antibiotics. Its MicrobeMiner platform mimics the stimuli in soil to unlock silent gene clusters in soil microbes, giving it access to untapped antibiotics. The platform is partly crowd-sourced: users can order a sample-collection kit, dig a soil sample and send it in for screening.

02 / FAILURE REASONS

Pending assessment

Material for this section is being gathered and checked. It will appear here once ready.

03 / EVENT HISTORY

Events in the structured record

  1. Founded

    Prospective Research, Inc. founded to develop novel antibiotics via its MicrobeMiner platform.

  2. MassBio member

    Listed as a MassBio member developing lifesaving antibiotics from soil microbes; SynBioBeta covered its crowd-sourced MicrobeMiner approach.

04 / CONTEMPORARY REBUILD ASSESSMENT

Difficulty of rebuilding this project today

Material for this section is being gathered and checked. It will appear here once ready.

Rebuild difficultyPending assessmentNot completed
Scoring basisNot completed
ScalabilityPending assessmentNot completed
Scoring basisNot completed

Overall assessment: Not completed

05 / CAUSAL CHAIN / AFTERMATH

Pending assessment

Material for this section is being gathered and checked. It will appear here once ready.